{"id":"https://openalex.org/W2884424744","doi":null,"title":"Abstract 14911: RDX227675, the Calcium Salt of a Novel Polystyrene Sulfonate-Based Resin, Reduces Potassium Absorption in Healthy Volunteers","display_name":"Abstract 14911: RDX227675, the Calcium Salt of a Novel Polystyrene Sulfonate-Based Resin, Reduces Potassium Absorption in Healthy Volunteers","publication_year":2016,"publication_date":"2016-11-11","ids":{"openalex":"https://openalex.org/W2884424744","mag":"2884424744"},"language":"en","primary_location":{"id":"mag:2884424744","doi":null,"is_oa":false,"landing_page_url":"https://www.ahajournals.org/doi/abs/10.1161/circ.134.suppl_1.14911","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Circulation","raw_type":null},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083976305","display_name":"Vanessa Zann","orcid":"https://orcid.org/0000-0003-0747-181X","observed_orcids":["https://orcid.org/0000-0003-0747-181X"]},"institutions":[{"id":"https://openalex.org/I4210133093","display_name":"Quotient Clinical (United Kingdom)","ror":"https://ror.org/03hjfdx24","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210133093"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Vanessa Zann","raw_affiliation_strings":["Quotient Clinical, Quotient Clinical, Nottingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quotient Clinical, Quotient Clinical, Nottingham, United Kingdom","institution_ids":["https://openalex.org/I4210133093"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109404511","display_name":"Chris Roe","orcid":"https://orcid.org/0000-0001-6988-5132","observed_orcids":["https://orcid.org/0000-0001-6988-5132"]},"institutions":[{"id":"https://openalex.org/I4210133093","display_name":"Quotient Clinical (United Kingdom)","ror":"https://ror.org/03hjfdx24","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210133093"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Chris Roe","raw_affiliation_strings":["Quotient Clinical, Quotient Clinical, Nottingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quotient Clinical, Quotient Clinical, Nottingham, United Kingdom","institution_ids":["https://openalex.org/I4210133093"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086027097","display_name":"Jeffrey W. Jacobs","orcid":"https://orcid.org/0000-0002-5893-4397","observed_orcids":["https://orcid.org/0000-0002-5893-4397"]},"institutions":[{"id":"https://openalex.org/I4210147970","display_name":"Ardelyx (United States)","ror":"https://ror.org/03wcj2062","country_code":"US","type":"company","lineage":["https://openalex.org/I4210147970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Jacobs","raw_affiliation_strings":["Ardelyx Inc., Ardelyx Inc., Fremont, CA"],"raw_orcid":"https://orcid.org/0000-0002-5893-4397","affiliations":[{"raw_affiliation_string":"Ardelyx Inc., Ardelyx Inc., Fremont, CA","institution_ids":["https://openalex.org/I4210147970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038844502","display_name":"James P. Davidson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147970","display_name":"Ardelyx (United States)","ror":"https://ror.org/03wcj2062","country_code":"US","type":"company","lineage":["https://openalex.org/I4210147970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James P. Davidson","raw_affiliation_strings":["Ardelyx Inc., Ardelyx Inc., Fremont, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ardelyx Inc., Ardelyx Inc., Fremont, CA","institution_ids":["https://openalex.org/I4210147970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082566986","display_name":"Robert C. Blanks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147970","display_name":"Ardelyx (United States)","ror":"https://ror.org/03wcj2062","country_code":"US","type":"company","lineage":["https://openalex.org/I4210147970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R.C. Blanks","raw_affiliation_strings":["Ardelyx Inc., Ardelyx Inc., Fremont, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ardelyx Inc., Ardelyx Inc., Fremont, CA","institution_ids":["https://openalex.org/I4210147970"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075827092","display_name":"David P. Rosenbaum","orcid":"https://orcid.org/0000-0002-9371-391X","observed_orcids":["https://orcid.org/0000-0002-9371-391X"]},"institutions":[{"id":"https://openalex.org/I4210147970","display_name":"Ardelyx (United States)","ror":"https://ror.org/03wcj2062","country_code":"US","type":"company","lineage":["https://openalex.org/I4210147970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David P. Rosenbaum","raw_affiliation_strings":["Ardelyx Inc., Ardelyx Inc., Fremont, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ardelyx Inc., Ardelyx Inc., Fremont, CA","institution_ids":["https://openalex.org/I4210147970"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"134","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12876","display_name":"Potassium and Related Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12876","display_name":"Potassium and Related Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10516","display_name":"Parathyroid Disorders and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/calcium-salts","display_name":"calcium salts","score":0.7699999809265137},{"id":"https://openalex.org/keywords/potassium-uptake","display_name":"potassium uptake","score":0.8980000019073486},{"id":"https://openalex.org/keywords/hyperkalemia","display_name":"hyperkalemia","score":0.9399999976158142},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.6489999890327454},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/renin-angiotensin-system-inhibitors","display_name":"renin-angiotensin system inhibitors","score":0.824999988079071},{"id":"https://openalex.org/keywords/potassium-binding-resin","display_name":"potassium-binding resin","score":0.5550000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8883442878723145},{"id":"https://openalex.org/C517785266","wikidata":"https://www.wikidata.org/wiki/Q703","display_name":"Potassium","level":2,"score":0.7516964077949524},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.6848863363265991},{"id":"https://openalex.org/C2776371256","wikidata":"https://www.wikidata.org/wiki/Q12370","display_name":"Salt (chemistry)","level":2,"score":0.62579345703125},{"id":"https://openalex.org/C125287762","wikidata":"https://www.wikidata.org/wiki/Q1758948","display_name":"Absorption (acoustics)","level":2,"score":0.5521069765090942},{"id":"https://openalex.org/C2777922577","wikidata":"https://www.wikidata.org/wiki/Q146243","display_name":"Polystyrene","level":3,"score":0.478851318359375},{"id":"https://openalex.org/C2778894819","wikidata":"https://www.wikidata.org/wiki/Q922718","display_name":"Sulfonate","level":3,"score":0.4406786859035492},{"id":"https://openalex.org/C13965031","wikidata":"https://www.wikidata.org/wiki/Q243545","display_name":"Nuclear chemistry","level":1,"score":0.3877618908882141},{"id":"https://openalex.org/C537181965","wikidata":"https://www.wikidata.org/wiki/Q658","display_name":"Sodium","level":2,"score":0.3035380244255066},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21945282816886902},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.1271439492702484},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.11382964253425598},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.08197399973869324},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2884424744","doi":null,"is_oa":false,"landing_page_url":"https://www.ahajournals.org/doi/abs/10.1161/circ.134.suppl_1.14911","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Circulation","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2797571741","https://openalex.org/W2767434013","https://openalex.org/W4240922281","https://openalex.org/W2318757819","https://openalex.org/W2165615563","https://openalex.org/W2952908565","https://openalex.org/W163984843","https://openalex.org/W2114993721","https://openalex.org/W2752882297","https://openalex.org/W2416002066"],"abstract_inverted_index":{"Introduction:":[0],"Patients":[1],"with":[2],"heart":[3],"failure":[4],"or":[5],"chronic":[6],"kidney":[7],"disease,":[8],"especially":[9],"those":[10],"taking":[11],"RAAS":[12],"inhibitors,":[13],"are":[14],"at":[15],"high":[16],"risk":[17],"of":[18],"developing":[19],"hyperkalemia,":[20],"which":[21],"can":[22],"lead":[23],"to":[24],"consequences":[25],"such":[26],"as":[27],"sud...":[28]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2018-08-03T00:00:00"}